Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages

Autophagy. 2011 Mar;7(3):321-30. doi: 10.4161/auto.7.3.14583.

Abstract

Phagocytosis of naturally dying cells usually blocks inflammatory reactions in host cells. We have recently observed that clearance of cells dying through autophagy leads to a pro-inflammatory response in human macrophages. Investigating this response further, we found that during engulfment of MCF-7 or 293T cells undergoing autophagic death, but not apoptotic or anoikic ones, caspase-1 was activated and IL-1β was processed, then secreted in a MyD88-independent manner. Autophagic dying cells were capable of preventing some LPS-induced pro-inflammatory responses, such as TNFα, IL-6 and IL-8 induction, but synergized with LPS for IL-1β production. Caspase-1 inhibition prevented macrophage IL-1β release triggered by the dying cells and also other pro-inflammatory cytokines which were not formed in the presence of IL-1 receptor antagonist anakinra either. IL-1β secretion was also observed using calreticulin knock down or necrostatin treated autophagic MCF-7 cells and it required phagocytosis of the dying cells which led to ATP secretion from macrophages. Blocking K (+) efflux during phagocytosis, the presence of apyrase, adding an antagonist of the P2X7 receptor or silencing the NOD-like receptor protein NALP3 inhibited IL-1β secretion. These data suggest that during phagocytosis of autophagic dying cells ATP, acting through its receptor, initiates K (+) efflux, inflammasome activation and secretion of IL-1β, which initiates further pro-inflammatory events. Thus, autophagic death of malignant cells and their clearance may lead to immunogenic response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Autophagy* / drug effects
  • Cell Line, Tumor
  • Humans
  • Inflammasomes / metabolism*
  • Inflammation Mediators / metabolism
  • Interleukin-1beta / metabolism*
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Myeloid Differentiation Factor 88 / metabolism
  • Receptors, Purinergic P2X7 / metabolism

Substances

  • IL1B protein, human
  • Inflammasomes
  • Inflammation Mediators
  • Interleukin-1beta
  • Lipopolysaccharides
  • Myeloid Differentiation Factor 88
  • Receptors, Purinergic P2X7
  • Adenosine Triphosphate